Cargando…
Association of immunohistochemical markers with premalignancy in Gonadal Dysgenesis
BACKGROUND: Gonadal dysgenesis (GD) is associated with increased risk of gonadal malignancy. Determining a patient’s risk and appropriate timing of gonadectomy is challenging, but immunohistochemical markers (IHM) may help establish the diagnosis of malignant germ cell tumors (GCT). Our objective wa...
Autores principales: | McCann-Crosby, Bonnie, Gunn, Sheila, Smith, E. O’Brian, Karaviti, Lefkothea, Hicks, M. John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472165/ https://www.ncbi.nlm.nih.gov/pubmed/26089923 http://dx.doi.org/10.1186/s13633-015-0010-6 |
Ejemplares similares
-
State of the art review in gonadal dysgenesis: challenges in diagnosis and management
por: McCann-Crosby, Bonnie, et al.
Publicado: (2014) -
MON-075 Autonomy and Self-Determination in a Patient with XY Gonadal Dysgenesis
por: Moryan-Blanchard, Kristen, et al.
Publicado: (2020) -
SUN-205 A Case of 46XY Mixed Gonadal Dysgenesis Presenting with Unilateral Gonad and Hemiuterus: Family History Dictates Sex Assignment
por: Al-Gadi, Iman, et al.
Publicado: (2019) -
Early development of a gonadal tumor in a patient with mixed gonadal dysgenesis
por: Cunha, Sarah Crestian, et al.
Publicado: (2018) -
Hemoptysis: A Rare Presentation of Mixed Gonadal Dysgenesis
por: Das, Darvin V., et al.
Publicado: (2020)